News

GSK boosts annual growth outlook as second-quarter profit beats forecasts
The development is a positive step towards GSK's long-term ambition to meet annual sales of more than 40 billion pounds ...
Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight
DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current treatment practices, triple-negative breast cancer emerging drugs, market share of ...
Will your next CEO be AI?
Fiction has been preparing us for an unseen, all knowing CEO for decades. Now technology could make it reality.
DelveInsight Business Research, LLP: Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...
Zacks Investment Research on MSN20h
Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
Pfizer (PFE) Gets a Hold from Citi
Pfizer has an analyst consensus of Hold, with a price target consensus of $28.50, implying a 14.97% upside from current levels. In a report released yesterday, Bernstein also maintained a Hold rating ...